Star Trek: Voyager’s sequel miniseries is reaching its conclusion, and now IDW Publishing has released the first advanced ...

Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 - - Sharpened focus on ...

In late 2023, NASA's Voyager 1—the most distant human-made object—fell eerily silent. For five months, the spacecraft, now ...

Overview Premium build with water-resistant vegan leather and ballistic nylonFour smart compartments, velvet laptop sleeve & ...

CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company ...

The Harvard astrophysicist urges the research community to include technological artifacts in the training data set ...

Voyager is paying travel partner Transition Bio a single-digit million-dollar upfront payment, with additional payments up to ...

Detailed price information for Churchill Capital Corp X Cl A (CCCX-Q) from The Globe and Mail including charting and trades.

Voyager Technologies, Inc. ("Voyager") (NYSE: VOYG) today announced its intention to offer, subject to market and other conditions, $300 million aggregate principal amount of convertible senior notes ...

Voyager Technologies, Inc. ("Voyager") (NYSE: VOYG) today announced the pricing of its offering of $435,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the "notes") in a ...

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Monday reported a loss of $27.9 million in its third quarter. On a per-share basis, the Lexington, ...

Voyager Technologies upsizes its convertible notes offering to $435M, raising funds for share buybacks and growth.